Journal of Medicinal Chemistry · 1996 · 43 citations · 20 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryStructure-activity RelationshipsSynthetic Medicinal ChemistryAntiviral PharmacologyHeterocyclic ChemistryMacrocycle SynthesisAntiviral Structure-activity RelationshipsMedicinal HeterocyclesNucleoside Analog SynthesisNucleoside AnalogsNucleoside Analogue AntiviralsSugar Nucleosides
The syntheses and the antiviral activities of 2-halo derivatives of neplanocin A (1b,c), (6'R)-6'-C-methylneplanocin A (2b), and dehydroxymethylneplanocin A (3b,c) are described. SN2 reaction of the known cyclopentenyl units 12 and 13 with 2-haloadenines under basic conditions gave the protected carbocyclic nucleosides 14b,c and 15b,c, respectively. Starting from the cyclopentenone derivative 5, the optically active tosyloxycyclopentene derivative 11 was prepared, which was similarly condensed with 2-fluoroadenine to give the protected (6'R)-6'-C-methyl derivative 16b. Deprotection of these compounds afforded the target 2-halo derivatives of neplanocin A. Of these new compounds, 2-fluoroneplanocin A (1b) showed an antiviral potency and a spectrum that was comparable to that of neplanocin A (1a). It was particularly active against vaccinia virus, vesicular stomatitis virus, parainfluenza virus, reovirus, arenaviruses (Junin, Tacaribe), and human cytomegalovirus, i.e., those viruses that fall within the purview of the S-adenosyl-L-homocysteine hydrolase inhibitors.
20
Suppression of mouse viraemia and retroviral disease by 3′-azido-3′-deoxythymidine
Ruth M. Ruprecht, Luke G. O'Brien, Lucia D. Rossoni et al. · Nature · 1986 · 244 citations
Jan Balzarini, Lieve Naesens, Piet Herdewijn et al. · Proceedings of the National Academy of Sciences · 1989 · 218 citations · Full text
Medicine, Oncology, Pharmacology +11
Shirô Shigeta, S Mori, Masanori Baba et al. · Antimicrobial Agents and Chemotherapy · 1992 · 109 citations · Full text